Avalo Therapeutics, Inc. · NASDAQ:AVTX

Nantahala Capital Management, LLC's stake in Avalo Therapeutics, Inc. fell to 3.54% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Nantahala Capital Management, LLC's stake in Avalo Therapeutics, Inc. fell to 3.54%, 1,862,250 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
3.54%
Shares
1,862,250
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC3.54%1,862,250
Wilmot B. Harkey3.54%1,862,250
Daniel Mack3.54%1,862,250

Source

View original at SEC

Related